As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value.
Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.
This report shines a spotlight on the latest category: Wound care.
Related content
![](/content/dam/optum4/resources/images/wf8630361-658984305-formulary-1080x720.jpg)
Case study: Strategic formulary changes
How a third-party administrator helped clients save $6.49 PMPM.
![](/content/dam/optum4/images/sub-folder/5619367-thought-leadership-vigilant-image-a-500x350.jpg)
Don't pay 5,000% more for commonly available generic drugs
This widespread practice costs plans millions.
![](/content/dam/o4-dam/images/professionals/pharmacies/patient-prescription-hands-1080x720.jpg)
How to eliminate prescription waste
Achieve savings by targeting expensive, low-value drugs.
Top